Search research articles
Contact Us
Filters
Showing results (61-70 of 97) with videos related to
Page
of 10
Sort By:
Diabetes, Obesity & Metabolism
|
April 25, 2020
Days absent from work as a result of complications associated with type 2 diabetes: Evidence from 20 years of linked national registry data in Sweden
Sofie Persson, Pierre Johansen, Emelie Andersson, et al.
Journal of the American Society of Hypertension : JASH
|
March 18, 2018
Effects on repetitive 24-hour ambulatory blood pressure in subjects with type II diabetes randomized to liraglutide or glimepiride treatment both in combination with metformin: a randomized open parallel-group study
Johan Jendle, Xin Fang, Yang Cao, et al.
Frontiers in Endocrinology
|
November 30, 2017
Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
Thomas Nyström, Irene Santos-Pardo, Fredric Hedberg, et al.
Frontiers in Endocrinology
|
March 2, 2018
Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
Thomas Nyström, Irene Santos-Pardo, Fredric Hedberg, et al.
Scientific Reports
|
March 31, 2026
Effects of automated insulin delivery systems on glucose control in subgroups of adults with type 1 diabetes in clinical practice over 2 years in Sweden
Ramanjit Singh, Henrik Imberg, Shilan Seyed Ahmadi, et al.
Diabetes, Obesity & Metabolism
|
May 7, 2021
Real-world performance of the MiniMed™ 670G system in Europe
Julien Da Silva, Emanuele Bosi, Johan Jendle, et al.
Journal of Diabetes Science and Technology
|
April 17, 2024
Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes
Ramanjit Singh, Henrik Imberg, Shilan Seyed Ahmadi, et al.
Diabetes Technology & Therapeutics
|
October 6, 2023
A European Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes
Johan Jendle, Maria Ida Buompensiere, Asli Zeynep Ozdemir Saltik, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 10, 2019
Switching to Degludec From Other Basal Insulins Is Associated With Reduced Hypoglycemia Rates: A Prospective Study
Gian Paolo Fadini, Michael Feher, Troels Krarup Hansen, et al.
Journal of Translational Medicine
|
January 4, 2026
The need for clear medical data ownership laws
David C Klonoff, Agatha F Scheideman, Mandy M Shao, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 97) with videos related to
Sort By:
Page
of 10
Diabetes, Obesity & Metabolism
|
April 25, 2020
Days absent from work as a result of complications associated with type 2 diabetes: Evidence from 20 years of linked national registry data in Sweden
Sofie Persson, Pierre Johansen, Emelie Andersson, et al.
Journal of the American Society of Hypertension : JASH
|
March 18, 2018
Effects on repetitive 24-hour ambulatory blood pressure in subjects with type II diabetes randomized to liraglutide or glimepiride treatment both in combination with metformin: a randomized open parallel-group study
Johan Jendle, Xin Fang, Yang Cao, et al.
Frontiers in Endocrinology
|
November 30, 2017
Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
Thomas Nyström, Irene Santos-Pardo, Fredric Hedberg, et al.
Frontiers in Endocrinology
|
March 2, 2018
Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
Thomas Nyström, Irene Santos-Pardo, Fredric Hedberg, et al.
Scientific Reports
|
March 31, 2026
Effects of automated insulin delivery systems on glucose control in subgroups of adults with type 1 diabetes in clinical practice over 2 years in Sweden
Ramanjit Singh, Henrik Imberg, Shilan Seyed Ahmadi, et al.
Diabetes, Obesity & Metabolism
|
May 7, 2021
Real-world performance of the MiniMed™ 670G system in Europe
Julien Da Silva, Emanuele Bosi, Johan Jendle, et al.
Journal of Diabetes Science and Technology
|
April 17, 2024
Effects, Safety, and Treatment Experience of Advanced Hybrid Closed-Loop Systems in Clinical Practice Among Adults Living With Type 1 Diabetes
Ramanjit Singh, Henrik Imberg, Shilan Seyed Ahmadi, et al.
Diabetes Technology & Therapeutics
|
October 6, 2023
A European Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes
Johan Jendle, Maria Ida Buompensiere, Asli Zeynep Ozdemir Saltik, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 10, 2019
Switching to Degludec From Other Basal Insulins Is Associated With Reduced Hypoglycemia Rates: A Prospective Study
Gian Paolo Fadini, Michael Feher, Troels Krarup Hansen, et al.
Journal of Translational Medicine
|
January 4, 2026
The need for clear medical data ownership laws
David C Klonoff, Agatha F Scheideman, Mandy M Shao, et al.
Page
of 10